Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension

Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension Clinical Trial

Status Completed

Clinical Trial Summary

In this randomized-controlled, cross-over trial the investigators test the effect of long-term oxygen therapy (> 16h/day) given for 5 weeks with a wash-out period between phases of 2 weeks on exercise performance and quality of life and many physiological parameters in patients with pulmonary arterial and chronic thromboembolic pulmonary hypertension.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Hypertension
• Hypertension, Pulmonary
• Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension

• NCT number: NCT01884012
• Study type: Interventional
• Source: University of Zurich
• Status: Completed
• Phase: Phase 3
• Start date: May 2013
• Completion date: March 2017